Lexicon Pharma net loss improves in Q2

|About: Lexicon Pharmaceuticals, Inc. (LXRX)|By:, SA News Editor

Lexicon Pharmaceuticals (LXRX) Q2 results: Revenues: $12.1M (-39.8%); Operating Loss: ($33.9M) (+8.4%); Net Loss: ($35.1M) (+7.9%); Loss Per Share: ($0.33) (+10.8%); Quick Assets: $231.2M (-33.3%).

No guidance given.

Subscribe for full text news in your inbox